HSPA5 and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC) and glioblastoma multiforme (GBM), for example, overexpression of CS-GRP78 is one of the responsibles for radio-resistance [214], while administration of anti-GRP78 delayed tumor growth and enhanced the efficacy of the radiation treatment.